This article will be permanently flagged as inappropriate and made unaccessible to everyone. Are you certain this article is inappropriate? Excessive Violence Sexual Content Political / Social
Email Address:
Article Id: WHEBN0025278076 Reproduction Date:
Ladostigil (TV-3,326) is a novel neuroprotective agent being investigated for the treatment of neurodegenerative disorders like Alzheimer's disease, Lewy body disease, and Parkinson's disease.[1] It acts as a reversible acetylcholinesterase and butyrylcholinesterase inhibitor, and an irreversible monoamine oxidase B inhibitor, and combines the mechanisms of action of older drugs like rivastigmine and rasagiline into a single molecule.[2][3] In addition to its neuroprotective properties, ladostigil enhances the expression of neurotrophic factors like GDNF and BDNF, and may be capable of reversing some of the damage seen in neurodegenerative diseases via the induction of neurogenesis.[4] Ladostigil also has antidepressant effects, and may be useful for treating comorbid depression and anxiety often seen in such diseases as well.[5][6]
: PSO/PSI
(, , , , , , ), /,
proc (/), drug (/////)
: CNS
(////////////)//
(/////)//, /,
, drug (////////)
Note: Many of the AChE inhibitors listed above also act as BChE inhibitors.
Sociology, Social psychology, Memory, Experimental psychology, Psychology
Medicine, Schizophrenia, Psychology, Psychotherapy, Neuroimaging
Carbon, Hydrogen, Oxygen, United States, Enzyme
Methamphetamine, Addiction, Norepinephrine, Gene expression, PubChem
Ergoline, Serotonin, Methamphetamine, Amphetamine, Lysergic acid diethylamide
Psychology, Psychiatry, Caffeine, Acetylcholine, Methamphetamine
Methamphetamine, Amphetamine, Iron, Zinc, Methyldopa
Benzatropine, Amphetamine, Xenon, Histamine, Carbon
International Union of Pure and Applied Chemistry nomenclature, American Society of Health-System Pharmacists, Drugs.com, Regulation of therapeutic goods, Route of administration